No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1849卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93387-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Reactions Weekly, 2021, 1848 (1) : 1 - 1
[2] Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Reactions Weekly, 2021, 1882 (1) : 9 - 9
[3] AstraZeneca COVID-19 vaccine: no increased rate of VTE
Reactions Weekly, 2021, 1850 (1) : 8 - 8
[4] COVID-19 vaccine and anaphylaxis
Joob, B.
Wiwanitkit, V.
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2021, 205 (06): : 631 - 631
[5] Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
[6] AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Reactions Weekly, 2021, 1851 (1) : 1 - 2
[7] Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
Caminati, Marco
Guarnieri, Gabriella
Senna, Gianenrico
VACCINES, 2021, 9 (01)
[8] COVID-19 vaccine anaphylaxis: PEG or not?
Krantz, Matthew S.
Liu, Yiwei
Phillips, Elizabeth J.
Stone, Cosby A., Jr.
ALLERGY, 2021, 76 (06) : 1934 - 1937
[9] AstraZeneca COVID-19 Vaccine-related risk of capillary leak syndrome
Reactions Weekly, 2021, 1864 (1) : 1 - 1
[10] Acute rejection following COVID-19 vaccine (AstraZeneca)
Varma, Prem P.
Kute, Vivek B.
Kumar, Prateek
INDIAN JOURNAL OF TRANSPLANTATION, 2022, 16 (04) : 465 - 466

← 1 2 3 4 5 →